The Offering has been increased from 15,000,000 units (the 'Units') at a price of
Each Warrant will entitle the holder to purchase one additional Common Share at a price of
The number of securities issuable pursuant to the Offering including both the Common Shares and the Warrants is higher than 25% of the number of the Company's issued and outstanding common shares (on a non-diluted basis). Therefore, pursuant to the requirements of the
The closing of the Offering is expected to occur on or about
The Company may pay finders fees of up to 5% of gross proceeds raised, payable in cash or Common Shares.
About
Laramide is a Canadian-based company with diversified uranium assets strategically positioned in
Forward-Looking Information
This release includes certain statements that may be deemed 'forward-looking statements'. All statements in this release, other than statements of historical facts, that address future production, reserve potential, exploration drilling, exploitation activities and events or developments that the Company expects are forward-looking statements. Although the Company believes the expectations expressed in such statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the statements. There are certain factors that could cause actual results to differ materially from those in forward-looking statements. These include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. For more information on the Company, investors are encouraged to review the Company's public filings at www.sedar.com. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by law.
Contact:
Tel: +1 416.599.7363
Fax: +1 416.599.4959
Email: info@laramide.com
(C) 2020 Electronic News Publishing, source